104 related articles for article (PubMed ID: 21609684)
1. Automation and miniaturization of the bioluminescent UGT-Glo assay for screening of UDP-glucuronosyltransferase inhibition by various compounds.
Larson B; Kelts JL; Banks P; Cali JJ
J Lab Autom; 2011 Feb; 16(1):38-46. PubMed ID: 21609684
[TBL] [Abstract][Full Text] [Related]
2. High-throughput screening technologies for drug glucuronidation profiling.
Trubetskoy O; Finel M; Trubetskoy V
J Pharm Pharmacol; 2008 Aug; 60(8):1061-7. PubMed ID: 18644198
[TBL] [Abstract][Full Text] [Related]
3. Targeted screen for human UDP-glucuronosyltransferases inhibitors and the evaluation of potential drug-drug interactions with zafirlukast.
Oda S; Fujiwara R; Kutsuno Y; Fukami T; Itoh T; Yokoi T; Nakajima M
Drug Metab Dispos; 2015 Jun; 43(6):812-8. PubMed ID: 25834030
[TBL] [Abstract][Full Text] [Related]
4. Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substrates.
Fujiwara R; Nakajima M; Yamanaka H; Katoh M; Yokoi T
Drug Metab Dispos; 2008 Feb; 36(2):361-7. PubMed ID: 17998297
[TBL] [Abstract][Full Text] [Related]
5. Optimized assays for human UDP-glucuronosyltransferase (UGT) activities: altered alamethicin concentration and utility to screen for UGT inhibitors.
Walsky RL; Bauman JN; Bourcier K; Giddens G; Lapham K; Negahban A; Ryder TF; Obach RS; Hyland R; Goosen TC
Drug Metab Dispos; 2012 May; 40(5):1051-65. PubMed ID: 22357286
[TBL] [Abstract][Full Text] [Related]
6. Modulation of UDP-glucuronosyltransferase activity by endogenous compounds.
Ishii Y; Nurrochmad A; Yamada H
Drug Metab Pharmacokinet; 2010; 25(2):134-48. PubMed ID: 20460819
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of uridine diphosphate on UDP-glucuronosyltransferase.
Yokota H; Ando F; Iwano H; Yuasa A
Life Sci; 1998; 63(19):1693-9. PubMed ID: 9806225
[TBL] [Abstract][Full Text] [Related]
8. High throughput screening assay for UDP-glucuronosyltransferase 1A1 glucuronidation profiling.
Trubetskoy OV; Finel M; Kurkela M; Fitzgerald M; Peters NR; Hoffman FM; Trubetskoy VS
Assay Drug Dev Technol; 2007 Jun; 5(3):343-54. PubMed ID: 17638534
[TBL] [Abstract][Full Text] [Related]
9. Enantioselective inhibition of carprofen towards UDP-glucuronosyltransferase (UGT) 2B7.
Fang ZZ; Wang H; Cao YF; Sun DX; Wang LX; Hong M; Huang T; Chen JX; Zeng J
Chirality; 2015 Mar; 27(3):189-93. PubMed ID: 25502512
[TBL] [Abstract][Full Text] [Related]
10. In vitro assay of six UDP-glucuronosyltransferase isoforms in human liver microsomes, using cocktails of probe substrates and liquid chromatography-tandem mass spectrometry.
Seo KA; Kim HJ; Jeong ES; Abdalla N; Choi CS; Kim DH; Shin JG
Drug Metab Dispos; 2014 Nov; 42(11):1803-10. PubMed ID: 25122565
[TBL] [Abstract][Full Text] [Related]
11. Validated assay for studying activity profiles of human liver UGTs after drug exposure: inhibition and induction studies.
Donato MT; Montero S; Castell JV; Gómez-Lechón MJ; Lahoz A
Anal Bioanal Chem; 2010 Mar; 396(6):2251-63. PubMed ID: 20145913
[TBL] [Abstract][Full Text] [Related]
12. A fluorescence-based microplate assay for high-throughput screening and evaluation of human UGT inhibitors.
Zhou QH; Lv X; Tian ZH; Finel M; Feng L; Huo PC; Zhu YD; Lu Y; Hou J; Ge GB
Anal Chim Acta; 2021 Apr; 1153():338305. PubMed ID: 33714444
[TBL] [Abstract][Full Text] [Related]
13. Inhibition screening method of microsomal UGTs using the cocktail approach.
Gradinaru J; Romand S; Geiser L; Carrupt PA; Spaggiari D; Rudaz S
Eur J Pharm Sci; 2015 Apr; 71():35-45. PubMed ID: 25684194
[TBL] [Abstract][Full Text] [Related]
14. Natural and synthetic inhibitors of UDP-glucuronosyltransferase.
Grancharov K; Naydenova Z; Lozeva S; Golovinsky E
Pharmacol Ther; 2001 Feb; 89(2):171-86. PubMed ID: 11316519
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous Screening of Activities of Five Cytochrome P450 and Four Uridine 5'-Diphospho-glucuronosyltransferase Enzymes in Human Liver Microsomes Using Cocktail Incubation and Liquid Chromatography-Tandem Mass Spectrometry.
Lee B; Ji HK; Lee T; Liu KH
Drug Metab Dispos; 2015 Jul; 43(7):1137-46. PubMed ID: 25904760
[TBL] [Abstract][Full Text] [Related]
16. TokyoGreen derivatives as specific and practical fluorescent probes for UDP-glucuronosyltransferase (UGT) 1A1.
Terai T; Tomiyasu R; Ota T; Ueno T; Komatsu T; Hanaoka K; Urano Y; Nagano T
Chem Commun (Camb); 2013 Apr; 49(30):3101-3. PubMed ID: 23338213
[TBL] [Abstract][Full Text] [Related]
17. Enzyme kinetics of uridine diphosphate glucuronosyltransferases (UGTs).
Zhou J; Miners JO
Methods Mol Biol; 2014; 1113():203-28. PubMed ID: 24523115
[TBL] [Abstract][Full Text] [Related]
18. Measurements of UDP- glucuronosyltransferase (UGT) activities.
Coffman BL; Rios GR; Tephly TR
Curr Protoc Toxicol; 2002; Chapter 4():Unit4.3. PubMed ID: 23045083
[TBL] [Abstract][Full Text] [Related]
19. Structure-inhibition relationship of podophyllotoxin (PT) analogues towards UDP-glucuronosyltransferase (UGT) isoforms.
Qi JQ; Cao YF; Sun XY; Hong M; Fang ZZ; Meng DL; Sun DX
Pharmazie; 2015 Apr; 70(4):239-43. PubMed ID: 26012253
[TBL] [Abstract][Full Text] [Related]
20. Determination of drug glucuronidation and UDP-glucuronosyltransferase selectivity using a 96-well radiometric assay.
Di Marco A; D'Antoni M; Attaccalite S; Carotenuto P; Laufer R
Drug Metab Dispos; 2005 Jun; 33(6):812-9. PubMed ID: 15788539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
